Cargando…

Pharmacogenetics in Africa, an Opportunity for Appropriate Drug Dosage Regimens: on the Road to Personalized Healthcare

Detalles Bibliográficos
Autores principales:	Masimirembwa, C, Hasler, J A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674327/ http://dx.doi.org/10.1038/psp.2013.17

Ejemplares similares

Pharmacogenetics and pharmacogenomics in glaucoma therapeutics: the way to personalized therapy
por: Liao, Shiyu, et al.
Publicado: (2023)

A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis
por: Jung, Jin Ah, et al.
Publicado: (2015)

Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization
por: Ong, Frank S., et al.
Publicado: (2013)

Surgical leadership in Africa – challenges and opportunities
por: Frimpong-Boateng, Kwabena, et al.
Publicado: (2019)

A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population
por: Tong, Hoi Y., et al.
Publicado: (2016)

Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
por: Drozda, Katarzyna, et al.
Publicado: (2018)

A Proposal for an Individualized Pharmacogenetic-Guided Warfarin Dosage Regimen for Puerto Rican Patients Commencing Anticoagulation Therapy
por: Bosch, Luis Ángel Bermúdez
Publicado: (2014)

Pharmacogenetics of cancer therapy: breakthroughs from beyond?
por: Lu, Da-Yong, et al.
Publicado: (2015)

Encountering Pharmacogenetic Test Results in the Psychiatric Clinic
por: Bousman, Chad A, et al.
Publicado: (2021)

Exploring Pharmacogenetic Testing for Hypertension Management in China
por: Zhao, Zhenping, et al.
Publicado: (2023)

Formalizing drug indications on the road to therapeutic intent
por: Nelson, Stuart J, et al.
Publicado: (2017)

Personal experience: Hopes and fears - the road to recovery after psychotic illness
por: Tagore, Aashish
Publicado: (2014)

Delivering pharmacogenetic testing in a primary care setting
por: Mills, Rachel, et al.
Publicado: (2013)

Warfarin Dosage Response Related Pharmacogenetics in Chinese Population
por: Li, Siyue, et al.
Publicado: (2015)

How informative is a negative finding in a small pharmacogenetic study?
por: Bacanu, S-A, et al.
Publicado: (2012)

Pharmacometrics: Opportunity for Reducing Disease Burden in the Developing World: The Case of Africa
por: Pillai, G, et al.
Publicado: (2013)

A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen
por: Kast, Richard E., et al.
Publicado: (2020)

Pharmacogenetics – Challenges and Opportunities Ahead
por: Zanger, Ulrich M.
Publicado: (2010)

COVID-19: A Window of Opportunity for Positive Healthcare Reforms
por: Auener, Stefan, et al.
Publicado: (2020)

US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer
por: Shord, Stacy S., et al.
Publicado: (2023)

Pharmacogenetics in the Management of Coumarin Anticoagulant Therapy: The Way Forward or an Expensive Diversion?
por: Greaves, Mike
Publicado: (2005)

On the road to replication
por: Diffley, John FX
Publicado: (2016)

Opportunities for traditional Chinese medicine to address unmet challenges in modern healthcare
por: Cheng, Yung-Chi
Publicado: (2015)

Lignin biosynthesis: old roads revisited and new roads explored
por: Dixon, Richard A., et al.
Publicado: (2019)

Bayesian Network Applications for Sustainable Holistic Water Resources Management: Modeling Opportunities for South Africa
por: Govender, Indrani Hazel, et al.
Publicado: (2021)

(Poly)phenolic compounds and gut microbiome: new opportunities for personalized nutrition
por: Narduzzi, Luca, et al.
Publicado: (2022)

Challenges in healthcare financing for surgery in sub-Saharan Africa
por: Okoroh, Juliet Siena, et al.
Publicado: (2021)

Unlocking the hidden burden of epilepsy in Africa: Understanding the challenges and harnessing opportunities for improved care
por: Nicholas, Aderinto
Publicado: (2023)

A framework to guide dose & regimen strategy for clinical drug development
por: Sander, Oliver, et al.
Publicado: (2021)

Challenges and opportunities for improving access to approved neonatal drugs and devices
por: Lewis, Tamorah, et al.
Publicado: (2022)

Metformin and breast cancer: an opportunity for pharmacogenetics
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Opportunities and Challenges of Using Big Data to Detect Drug‐Drug Interaction Risk
por: Quinney, Sara K.
Publicado: (2019)

European Health Data Space—An Opportunity Now to Grasp the Future of Data-Driven Healthcare
por: Horgan, Denis, et al.
Publicado: (2022)

Personalized Drug Dosage – Closing the Loop
por: Tucker, Geoffrey T
Publicado: (2016)

Model Informed Drug Development and Regulation in China: Challenges and Opportunities
por: Li, Li, et al.
Publicado: (2019)

Digital Technologies: Advancing Individualized Treatments through Gene and Cell Therapies, Pharmacogenetics, and Disease Detection and Diagnostics
por: Corridon, Peter R., et al.
Publicado: (2022)

Mastering Prognostic Tools: An Opportunity to Enhance Personalized Care and to Optimize Clinical Outcomes in Physical Therapy
por: Tousignant-Laflamme, Yannick, et al.
Publicado: (2022)

Challenges and opportunities for mining adverse drug reactions: perspectives from pharma, regulatory agencies, healthcare providers and consumers
por: Gonzalez-Hernandez, Graciela, et al.
Publicado: (2022)

Versatile applications of deep eutectic solvents in drug discovery and drug delivery systems: Perspectives and opportunities
por: Hayyan, Maan
Publicado: (2023)

Pharmacogenetic Testing: A Tool for Personalized Drug Therapy Optimization
por: Malsagova, Kristina A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q7v9faff9vn0td12gl255r9jav